Abstract: Lycopene is a natural dietary carotenoid which was reported to exhibit neuroprotective profile. Considering that excitotoxicity and cell death induced by glutamate are involved in many brain disorders, the effect of lycopene on glutamate release in rat cerebrocortical nerve terminals and the possible mechanism involved in such effect was investigated. We observed here that lycopene inhibited 4-aminopyridine (4-AP)-evoked glutamate release and intrasynaptosomal Ca 2+ concentration elevation. The inhibitory effect of lycopene on 4-AP-evoked glutamate release was markedly reduced in the presence of the Ca v 2.2 (N-type) and Ca v 2.1 (P/Q-type) channel blocker ω-conotoxin MVIIC, but was insensitive to the intracellular Ca 2+ -release inhibitors dantrolene and CGP37157. Furthermore, in the presence of the PKC inhibitors GF109203X and Go6976, the action of lycopene on evoked glutamate release was prevented. These results are the first to suggest that lycopene inhibits glutamate release from rat cortical synaptosomes by suppressing presynaptic Ca 2+ entry and PKC activity.
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of neurodegenerative disorders, especially Alzheimer's disease (Bun et al. 2015) . Although the underlying mechanism through which lycopene exerts its neuroprotective effect has not been clearly elucidated, inhibited inflammatory processes, antioxidant activity, oxygen-free radicals scavenging, and improved mitochondrial dysfunction have been implicated (Bhardwaj and Kumar 2016; Fujita et al. 2013; Sachdeva and Chopra 2015) .
Because excitoxicity mediated by excessive glutamate release is a mechanism of neuronal injury, implicated in the pathogenesis of many acute and chronic brain disorders, we used isolated nerve terminals (synaptosomes) prepared from the rat cerebral cortex to determine if lycopene could affect glutamate release. This preparation, being devoid of the cell-body, does not suffer from any complication of interpretation produced by concomitant postsynaptic effects, and is therefore extensively used to evaluate presynaptic effects on neurotransmitter release (Andrade-Talavera et al. 2012 Lonart and Sudhof 2000; Nicholls 1993;  Rodriguez-Moreno and Sihra 2013a). 
Materials and Methods

Animals
Glutamate release assay
Glutamate release was assayed by on-line fluorometry (Nicholls and Sihra 1986 [Ca 2+ ] C was measured with fura-2. Synaptosomes were resuspended (2 mg/mL) in HBM containing 16 µM BSA in the presence of 5 µM fura-2 and 0.1 mM CaCl 2 and incubated at 37°C
for 30 min in a stirred test tube. After fura-2 loading, synaptosomes were pelleted and resuspended in HBM containing BSA. The synaptosomal suspension was stirred in a thermostatted cuvette containing 1.2 mM CaCl 2 in a Perkin-Elmer LS-55 spectrofluorimeter, and the fluorescence was monitored at excitation wavelengths of 340 and 380 nm (emission wavelength 505 nm). Data was collected at 2-s intervals. [Ca 2+ ] C (nM) was calculated using the equations described by Grynkiewicz et al. (1985) . Cumulative data were analyzed using Lotus 1-2-3.
Data analysis
Data are presented as mean ± SEM. Student's unpaired t test or ANOVA was used for statistical analysis as appropriate; p values are reported throughout, and significance was set as p < 0.05.
Results
Synaptosomes were depolarized with the K + channel blocker 4-AP, which opens voltage-dependent Ca 2+ channels and induces the release of glutamate (Nicholls 1998) . Figure   1A shows that 4-AP (1 mM) evoked a glutamate release of 6.9 ± 0.1 nmol/mg/5 min from ; however, its precise mechanism remains unclear. In this work we have observed that lycopene inhibited evoked glutamate release in synaptosomes isolated from rat cerebral cortex, which may explain, at least in part, for its neuroprotective effect. This is because the excitotoxicity caused by excessive glutamate has been proposed to be involved in the pathogenesis of many brain diseases (Lipton and Rosenberg 1994; Rothstein 1996) . To the best of our knowledge, this study represents the first examination of the effect of lycopene on endogenous glutamate release at the presynaptic level. Several possible mechanisms for this effect are discussed as follows.
The release of glutamate produced by the depolarization of isolated nerve terminals has 2 components. A physiologically relevant Ca 2+ -dependent component is produced by the exocytosis of synaptic vesicles containing glutamate. A second, Ca 2+ -independent component is attributed to the reversal of the glutamate transporter (Nicholls 1998; Nicholls et al. 1987 experiments, using synaptosomal preparations from 5 to 7 animals. ***, P < 0.001 versus control group. #, P < 0.05 versus the DL-TBOA-treated group. Each column is mean ± SEM values of independent experiments, using synaptosomal preparations from 5 animals. ***, P < 0.001 versus control group. 
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